文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

欧洲区域麻疹消除进展(2009—2018年)

Progress Toward Measles Elimination - European Region, 2009-2018.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2019-05-03

本报告汇总WHO欧洲区域53国2009—2018年麻疹消除进展。期间MCV1估算区域覆盖率93%—95%,MCV2从73%升至90%;2017年仅30国(57%)MCV1≥95%、15国(28%)两剂均≥95%。

要点

  • 2017年仅57%国家MCV1≥95%,28%国家两剂均≥95%
  • 需确保各国各区两剂MCV≥95%并补充成人接种

核心结论

  • 欧洲区域麻疹消除尚未实现,2018年因多国大暴发发病率大幅回升。

研究设计与样本

  • 基于WHO欧洲区域53国2009—2018年麻疹监测与免疫覆盖率数据的进展报告。

主要发现

  • 2009—2017年MCV1估算区域覆盖率为93%—95%,MCV2从73%升至90%。
  • 2017年30国(57%)MCV1≥95%,15国(28%)两剂均≥95%。

关键数值与推荐

  • WHO推荐消除策略包括通过常规免疫使两剂MCV覆盖率达并维持≥95%。
  • 为易感人群提供麻疹和风疹疫苗接种机会,包括补充免疫活动。
  • 加强监测,开展病例调查并用实验室结果确认疑似病例和暴发。

临床怎么用

  • 各国各区应确保两剂MCV覆盖率达≥95%,并对易感成人补充接种。
  • 维持高质量监测以快速发现和确认病例,做好暴发准备与应对。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2010, all 53 countries* in the World Health Organization (WHO) European Region (EUR) reconfirmed their commitment to eliminating measles and rubella and congenital rubella syndrome (1); this goal was included as a priority in the European Vaccine Action Plan 2015-2020 (2). The WHO-recommended elimination strategies in EUR include 1) achieving and maintaining ≥95% coverage with 2 doses of measles-containing vaccine (MCV) through routine immunization services; 2) providing measles and rubella vaccination opportunities, including supplementary immunization activities (SIAs), to populations susceptible to measles or rubella; 3) strengthening surveillance by conducting case investigations and confirming suspected cases and outbreaks with laboratory results; and 4) improving the availability and use of evidence for the benefits and risks associated with vaccination (3). This report updates a previous report (4) and describes progress toward measles elimination in EUR during 2009-2018. During 2009-2017, estimated regional coverage with the first MCV dose (MCV1) was 93%-95%, and coverage with the second dose (MCV2) increased from 73% to 90%. In 2017, 30 (57%) countries achieved ≥95% MCV1 coverage, and 15 (28%) achieved ≥95% coverage with both doses. During 2009-2018, >16 million persons were vaccinated during SIAs in 13 (24%) countries. Measles incidence declined to 5.8 per 1 million population in 2016, but increased to 89.5 in 2018, because of large outbreaks in several EUR countries. To achieve measles elimination in EUR, measures are needed to strengthen immunization programs by ensuring ≥95% 2-dose MCV coverage in every district of each country, offering supplemental measles vaccination to susceptible adults, maintaining high-quality surveillance for rapid case detection and confirmation, and ensuring effective outbreak preparedness and response.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Zimmerman LA, Muscat M, Singh S, et al. Progress Toward Measles Elimination - European Region, 2009-2018. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31048675. doi:10.15585/mmwr.mm6817a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。